Cargando…

Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors

BACKGROUND: The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [(123)I]FP-CIT on a cadmium zinc telluride (CZT) camera, test the preexisting NaI-derived NDB for use in CZT scans...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Felix, Schau, Franziska, Rogasch, Julian M. M., Wetz, Christoph, Bluemel, Stephanie, Brenner, Winfried, Amthauer, Holger, Lange, Catharina, Schatka, Imke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033816/
https://www.ncbi.nlm.nih.gov/pubmed/36949290
http://dx.doi.org/10.1186/s13550-023-00973-8
_version_ 1784911071238160384
author Thiele, Felix
Schau, Franziska
Rogasch, Julian M. M.
Wetz, Christoph
Bluemel, Stephanie
Brenner, Winfried
Amthauer, Holger
Lange, Catharina
Schatka, Imke
author_facet Thiele, Felix
Schau, Franziska
Rogasch, Julian M. M.
Wetz, Christoph
Bluemel, Stephanie
Brenner, Winfried
Amthauer, Holger
Lange, Catharina
Schatka, Imke
author_sort Thiele, Felix
collection PubMed
description BACKGROUND: The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [(123)I]FP-CIT on a cadmium zinc telluride (CZT) camera, test the preexisting NaI-derived NDB for use in CZT scans, and compare the diagnostic findings in subjects imaged with a CZT scanner with either the preexisting NaI-based NDB or our newly defined CZT NDB. METHODS: The sample comprised 73 subjects with clinically uncertain parkinsonian syndrome (PS) who prospectively underwent [(123)I]FP-CIT SPECT on a CZT camera according to standard guidelines with identical acquisition and reconstruction protocols (DaTQUANT). Two experienced readers visually assessed the images and binarized the subjects into “non-neurodegenerative PS” and “neurodegenerative PS”. Twenty-five subjects from the “non-neurodegenerative PS” subgroup were randomly selected to establish a CZT NDB. The remaining 48 subjects were defined as “test group”. DaTQUANT was used to determine the specific binding ratio (SBR). For the test group, SBR values were transformed to z-scores for the putamen utilizing both the CZT NDB and the manufacturer-provided NaI-based NDB (GE NDB). A predefined fixed cut-off of -2 was used for dichotomization of z-scores to classify neurodegenerative and non-neurodegenerative PS. Performance of semiquantification using the two NDB to identify subjects with neurodegenerative PS was assessed in comparison with the visual rating. Furthermore, a randomized head-to-head comparison of both detector systems was performed semiquantitatively in a subset of 32 out of all 73 subjects. RESULTS: Compared to the visual rating as reference, semiquantification based on the dedicated CZT NDB led to fewer discordant ratings than the GE NDB in CZT scans (3 vs. 8 out of 48 subjects). This can be attributed to the putaminal z-scores being consistently higher with the GE NDB on a CZT camera (median absolute difference of 1.68), suggesting an optimal cut-off of -0.5 for the GE NDB instead of -2.0. Average binding ratios and z-scores were significantly lower in CZT compared to NaI data. CONCLUSIONS: Use of a dedicated, CZT-derived NDB is recommended in [(123)I]FP-CIT SPECT with a CZT camera since it improves agreement between semiquantification and visual assessment.
format Online
Article
Text
id pubmed-10033816
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100338162023-03-24 Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors Thiele, Felix Schau, Franziska Rogasch, Julian M. M. Wetz, Christoph Bluemel, Stephanie Brenner, Winfried Amthauer, Holger Lange, Catharina Schatka, Imke EJNMMI Res Original Research BACKGROUND: The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [(123)I]FP-CIT on a cadmium zinc telluride (CZT) camera, test the preexisting NaI-derived NDB for use in CZT scans, and compare the diagnostic findings in subjects imaged with a CZT scanner with either the preexisting NaI-based NDB or our newly defined CZT NDB. METHODS: The sample comprised 73 subjects with clinically uncertain parkinsonian syndrome (PS) who prospectively underwent [(123)I]FP-CIT SPECT on a CZT camera according to standard guidelines with identical acquisition and reconstruction protocols (DaTQUANT). Two experienced readers visually assessed the images and binarized the subjects into “non-neurodegenerative PS” and “neurodegenerative PS”. Twenty-five subjects from the “non-neurodegenerative PS” subgroup were randomly selected to establish a CZT NDB. The remaining 48 subjects were defined as “test group”. DaTQUANT was used to determine the specific binding ratio (SBR). For the test group, SBR values were transformed to z-scores for the putamen utilizing both the CZT NDB and the manufacturer-provided NaI-based NDB (GE NDB). A predefined fixed cut-off of -2 was used for dichotomization of z-scores to classify neurodegenerative and non-neurodegenerative PS. Performance of semiquantification using the two NDB to identify subjects with neurodegenerative PS was assessed in comparison with the visual rating. Furthermore, a randomized head-to-head comparison of both detector systems was performed semiquantitatively in a subset of 32 out of all 73 subjects. RESULTS: Compared to the visual rating as reference, semiquantification based on the dedicated CZT NDB led to fewer discordant ratings than the GE NDB in CZT scans (3 vs. 8 out of 48 subjects). This can be attributed to the putaminal z-scores being consistently higher with the GE NDB on a CZT camera (median absolute difference of 1.68), suggesting an optimal cut-off of -0.5 for the GE NDB instead of -2.0. Average binding ratios and z-scores were significantly lower in CZT compared to NaI data. CONCLUSIONS: Use of a dedicated, CZT-derived NDB is recommended in [(123)I]FP-CIT SPECT with a CZT camera since it improves agreement between semiquantification and visual assessment. Springer Berlin Heidelberg 2023-03-22 /pmc/articles/PMC10033816/ /pubmed/36949290 http://dx.doi.org/10.1186/s13550-023-00973-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Thiele, Felix
Schau, Franziska
Rogasch, Julian M. M.
Wetz, Christoph
Bluemel, Stephanie
Brenner, Winfried
Amthauer, Holger
Lange, Catharina
Schatka, Imke
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title_full Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title_fullStr Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title_full_unstemmed Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title_short Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
title_sort same same but different: dopamine transporter spect on scanners with czt vs. nai detectors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033816/
https://www.ncbi.nlm.nih.gov/pubmed/36949290
http://dx.doi.org/10.1186/s13550-023-00973-8
work_keys_str_mv AT thielefelix samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT schaufranziska samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT rogaschjulianmm samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT wetzchristoph samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT bluemelstephanie samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT brennerwinfried samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT amthauerholger samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT langecatharina samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors
AT schatkaimke samesamebutdifferentdopaminetransporterspectonscannerswithcztvsnaidetectors